Prinivil 5

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prinivil 5

What is Prinivil 5?

Prinivil 5 is a prescription medication containing 5 mg of lisinopril, which belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. It is primarily used to manage cardiovascular conditions by affecting the way the body regulates blood pressure and fluid balance.

Mechanism of Action

The active ingredient, lisinopril, works by inhibiting the ACE enzyme. This enzyme is responsible for converting angiotensin I into angiotensin II, a potent substance in the body that causes blood vessels to narrow or contract. By reducing the production of angiotensin II, the medication allows blood vessels to relax and widen. This process lowers peripheral vascular resistance, making it easier for the heart to pump blood throughout the body.

Primary Therapeutic Uses

Prinivil 5 is typically utilized in the following clinical contexts:

  • Hypertension: It is used to lower high blood pressure. Maintaining controlled blood pressure levels helps reduce the long-term risk of cardiovascular events such as strokes and myocardial infarctions.
  • Heart Failure: It may be used as part of a broader management plan for heart failure to improve cardiac output and reduce the workload on the heart muscle.
  • Post-Myocardial Infarction: In certain cases, it is administered following a heart attack to improve survival rates and help prevent the subsequent development of heart failure.

Physical Characteristics

As a 5 mg formulation, this specific strength is often used during the initial stages of treatment or for patients who require a lower dose based on their renal function or overall clinical profile. The tablets are designed for oral administration and provide a consistent release of the active medication over a 24-hour period.

Regulatory References

  1. Physiology, Renin Angiotensin System (RAAS)

What side effects are possible with Prinivil 5?

Official Safety Profile of Prinivil 5 (Lisinopril)

The safety profile of Prinivil 5, which contains the active ingredient Lisinopril, is documented in official government regulatory sources and categorized by frequency and the body system affected. These classifications distinguish between commonly reported events and rare, clinically significant reactions.


Adverse Reactions and Frequency Classification

Adverse reactions are formally grouped into categories based on their observed incidence:

  • Common (may affect up to 1 in 10 people): Dizziness, headache, and a persistent, dry cough. Other common effects include orthostatic hypotension, diarrhea, vomiting, and mild renal dysfunction.
  • Uncommon (may affect up to 1 in 100 people): Mood alterations, vertigo, taste disturbance, and dermatological reactions like rash and pruritus. Gastrointestinal effects such as nausea and abdominal pain are also documented.

Serious Adverse Reactions

The regulatory label specifies rare but potentially life-threatening adverse reactions that require immediate attention. These include Angioedema, which is rapid swelling of the face, tongue, glottis, and/or larynx, and fatal hepatic failure. Severe drops in blood pressure (hypotension) that may lead to secondary events like stroke or myocardial infarction are also noted, particularly in high-risk patients.


Safety Considerations for Specific Populations and Exposure

Regulatory documents include specific safety constraints for Prinivil 5:

  • Pregnancy: The medication is contraindicated during the second and third trimesters due to risk of fetal injury and death.
  • Time-Related Pattern: The risk of excessive hypotension may be most pronounced following the first dose or when the dosage is increased.
  • Limitations: Use requires caution and monitoring in patients with underlying conditions such as renal impairment or aortic stenosis. The risk of hyperkalemia (high potassium) is also a documented safety element, especially when used with potassium-sparing agents.

This structured information is based strictly on the official findings of health authorities, providing a clear overview of the medicine’s regulatory safety profile.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile of Lisinopril (Prinivil 5) as a condition resulting from an exaggeration of its therapeutic effects, primarily impacting the cardiovascular system. The most common manifestations documented are profound hypotension (excessively low blood pressure), resulting in symptoms such as dizziness and lightheadedness, and changes in heart rhythm, including bradycardia or tachycardia.

Overdose carries the potential for severe, life-threatening outcomes, including circulatory shock, cardiovascular collapse, and acute renal failure. Additionally, laboratory findings may reveal electrolyte disturbances, specifically hyperkalemia.

Required Emergency Action

It is mandatory to seek immediate medical attention or contact emergency services immediately upon the suspicion of overdose. Management described in regulatory sources is symptomatic and supportive. Treatment procedures may include placing the patient in the supine position, administering intravenous saline infusion to manage severe hypotension, and potentially using hemodialysis, as Lisinopril is dialyzable. No specific antidote is known for Lisinopril overdose. Close hospital monitoring of vital signs, serum electrolytes, and renal function is required during observation.

Therapeutic Uses of Prinivil 5

What Prinivil 5 Treats: Main Uses and Benefits

Prinivil 5 is generally considered relevant for addressing symptoms and systemic imbalance in conditions marked by increased physiological stress related to circulatory health. The drug is commonly used to help with hypertension, heart failure, and following an acute myocardial infarction. The overarching goal is to provide supportive relief to help ease the overall symptom burden.

The medication is commonly applied in scenarios requiring long-term stability and is relevant when supportive symptom management is appropriate across these domains. It may assist in managing the potential for serious complications like stroke, while also addressing symptomatic congestion. The therapeutic benefit supports the relief of symptoms linked to organ-specific functional stress.

“The key benefit generally contributes to maintaining functional stability across cardiovascular domains and assisting with the functional strain related to fluid retention.”

Quick Fact: Relief for Circulatory Strain

Prinivil 5 may be part of symptomatic management for symptoms related to heightened physiological activity and systemic imbalance, supporting patients during episodes of heightened discomfort related to these conditions, which can assist with maintaining functional stability.

Regulatory References

  1. NIH DailyMed official label for Lisinopril

Eligibility and Restrictions for Use

The official eligibility profile for Prinivil 5 (Lisinopril) is defined by a set of regulatory exclusions and restrictions related to age, physiological state, and coexisting conditions.

Contraindicated Populations

The medicine is absolutely contraindicated for patients with a known history of angioedema related to any previous ACE inhibitor treatment, or patients with hereditary or idiopathic angioedema. It is also prohibited for women in their second or third trimesters of pregnancy due to the risk of fetal injury and death. Concomitant use with aliskiren is contraindicated in patients with diabetes, and Prinivil 5 must not be taken within 36 hours of using a Neprilysin Inhibitor.

Restricted and Conditional Use

Category Regulatory Status
Pediatric Use Approved for hypertension in children 6 years of age and older; not recommended for those under 6 or for any pediatric patient with severe renal impairment (GFR < 30 mL/min/1.73m^2).
Renal Function Patients with impaired renal function (Creatinine Clearance le 30 mL/min) are eligible only with a required reduction in the initial dosage.
Lactation Not recommended as Lisinopril is secreted into breast milk, and the effect on the nursing infant is unknown.

Older adult patients and those who are volume- or salt-depleted require particular caution and potential dose adjustment upon initiation, as defined in official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Prinivil 5 (Lisinopril) is primarily structured around its effects on the body's fluid and electrolyte balance and its interaction with other cardiovascular agents.


Contraindications and Mandatory Separation

Co-administration is strictly contraindicated with Sacubitril/Valsartan, a neprilysin inhibitor, due to a significantly increased risk of angioedema. A mandatory 36-hour wash-out period is required when transitioning either to or from Lisinopril with this medication. Furthermore, Lisinopril is contraindicated with the direct renin inhibitor Aliskiren in patients diagnosed with diabetes or those with pre-existing moderate to severe renal impairment.


Pharmacodynamic and Exposure Interactions

Lisinopril may increase the risk of elevated serum potassium levels (hyperkalemia) when co-administered with Potassium-Sparing Diuretics (e.g., Spironolactone, Triamterene) or products such as Potassium Supplements and potassium-containing salt substitutes.

The co-administration of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) may reduce Lisinopril’s blood pressure lowering effect and increases the risk of renal function deterioration. Regulatory documents specifically note this risk is higher in elderly or volume-depleted individuals.

Lisinopril affects the excretion of Lithium, leading to its reduced renal clearance and an increased risk of Lithium toxicity. Co-administration with mTOR Inhibitors (e.g., Temsirolimus) is also associated with an increased angioedema risk. Alcohol consumption may enhance the hypotensive effects of Lisinopril. Regulatory documents confirm that Lisinopril's absorption is not influenced by food.

Mechanism of Action

Prinivil 5 (Lisinopril) modulates cardiovascular processes by acting as a specific competitive inhibitor of the Angiotensin-Converting Enzyme (ACE). This action engages two primary mechanistic domains to influence the mechanisms that govern pressure and volume within the circulatory system.

Suppression of the Angiotensin II Cascade

This domain addresses the drug's primary action on the Renin-Angiotensin-Aldosterone System (RAAS). By blocking ACE, Lisinopril prevents the synthesis of the vasoconstrictor Angiotensin II and limits its downstream hormonal effects, which is the initial molecular step resulting in lowered vascular tension.

Dual Modulation of Vascular Tone and Fluid Regulation

The resulting reduction in Angiotensin II triggers two physiological adjustments: it decreases vessel constriction to lower Systemic Vascular Resistance (SVR), and it suppresses the hormone aldosterone to promote the excretion of sodium and water. This dual mechanism—supported by the accumulation of the natural vasodilator bradykinin—results in a decrease in both the resistance (afterload) and the volume (preload) the heart must maintain.

Dosage and Administration Information

How to Use Prinivil 5 (Lisinopril)

Prinivil 5 is a prescription medication administered exclusively via the oral route as a tablet, taken once daily for all approved indications. The medicine may be taken with or without food, provided it is administered at approximately the same time each day to maintain consistent systemic levels. Doubling a dose is not recommended if the previous dose is missed; the patient should simply resume the usual schedule.


Official Dosing and Titration Principles

The general principle for use involves starting with a low dose and gradually increasing it based on clinical response. This process is known as titration.

Indication Typical Initial Adult Dose Maintenance Range Max Recommended Dose
Hypertension 10 mg once daily 20 mg to 40 mg once daily 80 mg once daily
Heart Failure 5 mg once daily Up to 40 mg once daily 40 mg once daily

For patients with Heart Failure, the dose should generally not be increased more frequently than every two weeks. For patients concurrently taking a diuretic, the initial dose is commonly reduced to 5 mg for hypertension management.

Population and Procedural Constraints

Dose adjustments are utilized for patients with impaired renal function. For example, those with severe renal impairment (creatinine clearance less than 10 mL/min) should be started at 2.5 mg once daily. Following an acute myocardial infarction, use should be continued for at least six weeks, establishing a minimum duration pattern.

Recent Clinical Evidence

Research evidence / Overview of Studies for Prinivil 5


Evidence Supporting Use for High Blood Pressure (Hypertension)

Research examined Prinivil primarily within numerous Randomized Controlled Trials (RCTs) and studies comparing different dosage levels. These studies were conducted to understand outcomes relative to an inactive substance (placebo) and other medications used for blood pressure. Researchers focused on measuring changes in blood pressure levels, specifically the systolic and diastolic readings, over both short and long periods. Findings describe patterns where groups receiving Prinivil reported measurements of reductions in their blood pressure readings, and research explored how these observations evolved over the study period.


Evidence Supporting Use After a Heart Attack (Acute Myocardial Infarction)

Research for Prinivil following a heart attack involves large-scale, early intervention trials. These studies, which often included thousands of patients globally, monitored outcomes when starting the medication within 24 hours of the initial symptoms. Research monitored two primary outcomes: all-cause mortality (death) rates and the frequency of subsequent non-fatal heart complications, such as cardiac failure. These pivotal trials reported patterns of all-cause mortality rates in patient groups that received early administration of the medication compared to control groups.


Evidence Supporting Use for Chronic Heart Failure

The body of research for heart failure primarily consists of major, long-term Randomized Controlled Trials (RCTs), many of which were placebo-controlled. These studies were applied in research contexts involving fluctuating or unstable symptoms and focused on assessing all-cause mortality and the rate of hospitalization due to heart failure-related events. Studies tracked and reported the all-cause mortality and hospitalization rates due to heart failure events in groups receiving the medication compared to control groups over study periods that often spanned several years.


Key Evidence Gaps and Research Uncertainty

Data are still emerging for non-hypertensive patients with diabetic kidney involvement. Research provides context but not individual predictions, and findings describe group patterns, not personal outcomes. The evidence highlights what is known and what is still uncertain: for example, the full scope of evaluation across all types of kidney disease (not just diabetic) is not established by these specific trials. The results reflect the specific conditions under which they were conducted and do not determine whether an individual will respond similarly.

Key Studies & References

  1. Lisinopril Official FDA-Approved Labeling Information (DailyMed)
  2. Hypertension: Clinical Management of Primary Hypertension in Adults (NICE Guideline)

Frequently Asked Questions (FAQ)

Common questions about Prinivil 5 (FAQ)


Q: Does Prinivil 5 work immediately after taking it?

Official information indicates that some blood pressure lowering activity is generally observed within one hour of taking a dose. The largest reduction in blood pressure typically occurs about six hours after administration. The medication is designed to maintain its effect for at least 24 hours with daily use.


Q: How long does it typically take to see the effects of Prinivil 5?

While an immediate effect on blood pressure is seen, the full, consistent benefits of Prinivil 5 (its steady-state effect) are usually established after taking the medication daily for approximately two to three days. Effectiveness is assessed by a healthcare provider over long-term use.


Q: Are there any foods or drinks to avoid while taking Prinivil 5?

Regulatory documents state that alcohol may enhance the blood pressure-lowering effect of the medication, and caution is suggested. Additionally, the use of potassium-containing salt substitutes or potassium supplements is associated with an increased risk of elevated potassium levels in the blood (hyperkalemia).


Q: Does alcohol interact with Prinivil 5?

Yes, official regulatory documents state that consuming alcohol can potentially enhance the hypotensive effects of Prinivil 5. This may cause a more pronounced drop in blood pressure.


Q: What should be done if someone experiences swelling while taking Prinivil?

The official safety documentation emphasizes that swelling of the face, tongue, or throat (angioedema) is a serious, documented adverse reaction. If this occurs, the medication should be promptly stopped, and it is necessary to seek prompt medical attention for appropriate treatment and monitoring until the swelling has fully resolved.


Q: Can Prinivil 5 cause changes in heart rate?

Generally, the medication is described in regulatory summaries as lowering blood pressure without directly affecting heart rate. However, the official label notes a risk of significant low blood pressure (hypotension), which can indirectly influence overall heart function. The medication is used to reduce strain on the cardiovascular system.


Q: What are the signs of a serious side effect from Prinivil 5?

Official safety profiles highlight rare but serious reactions such as Angioedema (sudden, severe swelling of the face or throat) and signs of serious Liver Failure (for example, yellowing of the skin or eyes). Severe drops in blood pressure (hypotension) are also noted as a risk, especially in high-risk individuals.


Q: What is the difference between Prinivil and Zestril?

Prinivil and Zestril are two different brand names that contain the exact same active ingredient: lisinopril. They are both considered chemically and therapeutically equivalent, according to regulatory standards.


Q: Can Prinivil 5 be used for conditions other than high blood pressure?

Yes, regulatory documents approve the use of Prinivil 5 to treat not only high blood pressure, but also to manage heart failure and to help improve survival outcomes for clinically stable patients following an acute heart attack.


Q: What are the most common side effects reported for Prinivil 5?

The most frequently reported adverse reactions documented in official regulatory sources include dizziness, headache, and a persistent, dry cough. Dizziness upon standing (orthostatic hypotension) is also commonly noted.


Q: Is it normal to feel dizzy when starting Prinivil 5?

Dizziness is documented as a common side effect. The official label notes that the risk of low blood pressure (hypotension) may be most noticeable after the first dose or when the dose is increased, which is why dizziness may be an initial experience.


Q: Can a person take Prinivil 5 if they have kidney problems?

The regulatory labeling specifies that Prinivil 5 requires careful management in patients with pre-existing impaired renal function (kidney problems). This typically includes an initial dose reduction and close monitoring of kidney function during treatment.


Q: What should be known about Prinivil 5 use in older adults?

Official documentation notes that older adult patients may be more susceptible to potential age-related kidney issues, which may necessitate a dose adjustment. The initiation of the medication may require caution, as some older individuals may show increased sensitivity to its effects.


Q: Can Prinivil 5 affect a person's mood or cause depression?

The regulatory safety profile lists mood alterations as an uncommon adverse reaction (may affect up to 1 in 100 people). Reports of depressed mood have also been noted in clinical studies that support the drug’s use.


Q: Are there any long-term effects associated with using Prinivil 5?

The medication is intended for long-term therapy for chronic conditions. The regulatory safety profile documents adverse reactions based on overall exposure, including effects like the persistent cough, which may continue during extended use. The effects are generally maintained over time.


Q: Does Prinivil 5 require frequent blood tests?

Yes, regulatory documents recommend that both kidney function (renal function) and serum potassium levels should be monitored periodically during treatment. This monitoring is particularly important when treatment is first started or in patients with underlying conditions.


Q: Is it okay to stop taking Prinivil 5 if blood pressure seems controlled?

The medication is used to manage chronic conditions like high blood pressure and heart failure. The duration of treatment is determined by the prescribing healthcare provider, and regulatory documents stress the need to adhere to the prescribed regimen.


Q: What are the ingredients in Prinivil 5 besides the active medication?

In addition to the active drug, Lisinopril, Prinivil 5 tablets contain various inactive ingredients (excipients). These components, which include binders, fillers, and coloring agents, are fully listed in the complete official product labeling.


Q: Does taking Prinivil 5 mean a person has to limit salt intake?

While the medication affects fluid and electrolyte balance, the official label does not prescribe a specific general salt restriction. However, it does caution against the use of potassium-containing salt substitutes due to the associated risk of hyperkalemia.


Q: Are there generic versions of Prinivil available?

Yes, the active ingredient in Prinivil, lisinopril, is widely available in many generic tablet forms. These generic products are approved by regulatory authorities as therapeutically equivalent to the brand-name product.


Q: How does Prinivil 5 affect blood sugar levels?

Some regulatory resources have noted that the medication may cause a slight decrease in blood sugar levels. For individuals with diabetes, monitoring of blood sugar levels may be suggested when treatment begins.


Q: What should a person know about Prinivil 5 before having surgery?

Regulatory documentation notes that Prinivil 5 may cause a drop in blood pressure (hypotension) when a patient is undergoing major surgery or anesthesia. Regulatory documents indicate the treatment team should be informed of the medication use beforehand.


Q: Does Prinivil 5 have a risk of anaphylactic reaction?

Yes, official documents specify the risk of anaphylactoid reactions (severe, systemic allergic-like reactions). These have been reported in rare circumstances, such as during certain types of desensitization treatments or dialysis procedures.


Q: Is Prinivil 5 a medication that needs to be taken for life?

The medication is approved for the management of chronic medical conditions, such as high blood pressure and heart failure, which often require long-term control. The duration of treatment is determined by the prescribing healthcare provider based on the chronic nature of the condition being managed.

How should Prinivil 5 be stored and disposed of?

How to Store and Dispose of Prinivil 5 (Lisinopril)

Official regulatory information mandates specific storage and disposal requirements to maintain product integrity and safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the container tightly closed and protect from excess moisture, heat, and direct light.
Prohibitions Do not freeze or store the medication in areas of high humidity (e.g., the bathroom).
Child Safety Store the medicine up, away, and out of the sight and reach of children.

Disposal Instructions

Expired or unused Prinivil 5 should be disposed of promptly. Consult a pharmacist or healthcare provider for specific guidance on drug disposal in your area. Consumers are generally advised to utilize official drug take-back programs when available. If a take-back program is not accessible, follow authorized instructions for household trash disposal, which involves mixing the medicine with an unappealing substance and sealing it before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prinivil 5 found in:

A-Z Index: